EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NF-κB in Alzheimer’s Disease: Friend or Foe? Opposite Functions in Neurons and Glial Cells

Barbara Kaltschmidt, Nele Johanne Czaniera, Wiebke Schulten, Christian Kaltschmidt

International Journal of Molecular Sciences · 22.10.2024 · 25 (21) · 11353

DOI: 10.3390/ijms252111353 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.10.2024. Verfasst von Barbara Kaltschmidt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Neurobiology, University of Bielefeld, 33615 Bielefeld, Germany. Hauptthemen laut MEDLINE: Alzheimer Disease, NF-kappa B, Neurons, Neuroglia. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, University of Bielefeld, FBMB e.V..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a devasting neurodegenerative disease afflicting mainly glutamatergic neurons together with a massive neuroinflammation mediated by the transcription factor NF-κB. A 65%-plus increase in Alzheimer’s patients by 2050 might be a major threat to society. Hallmarks of AD are neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau and amyloid beta (Aβ) plaques. Here, we review the potential involvement of transcription factor NF-κB by hereditary mutations of the tumor necrosis factor pathway in AD patients. One of the greatest genetic risk factors is APOE4. Recently, it was shown that the APOE4 allele functions as a null allele in human astrocytes not repressing NF-κB anymore. Moreover, NF-κB seems to be involved in the repair of DNA double-strand breaks during healthy learning and memory, a function blunted in AD. NF-κB could be a friend to healthy neurons by repressing apoptosis and necroptosis. But a loss of neuronal NF-κB and activation of glial NF-κB in AD makes it a foe of neuronal survival. Hopeful therapies include TNFR2 receptor bodies relieving the activation of glial NF-κB by TNFα.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNF-kappa BNeuronsNeurogliaHumansAnimalsTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

APOE4Alzheimer’s diseaseDNA breaksDNA damage repairNF-κBTNFglial cellsneuroinflammationtranscription factor

Substanzen

NF-kappa BTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Molecular Neurobiology, University of Bielefeld, 33615 Bielefeld, Germany.
  • Department of Cell Biology, University of Bielefeld, 33615 Bielefeld, Germany.
  • Forschungsverbund BioMedizin Bielefeld, Ostwestfalen-Lippe (OWL) (FBMB E.V.), 33615 Bielefeld, Germany.

Förderung

  • Deutsche Forschungsgemeinschaft
  • University of Bielefeld
  • FBMB e.V.
  • Hans Böckler Stiftung

Zitieren

APA

Kaltschmidt, B., Czaniera, N. J., Schulten, W., & Kaltschmidt, C. (2024). NF-κB in Alzheimer’s Disease: Friend or Foe? Opposite Functions in Neurons and Glial Cells. International Journal of Molecular Sciences, 25(21), 11353. https://doi.org/10.3390/ijms252111353

Vancouver

Kaltschmidt B, Czaniera NJ, Schulten W, Kaltschmidt C. NF-κB in Alzheimer’s Disease: Friend or Foe? Opposite Functions in Neurons and Glial Cells. International Journal of Molecular Sciences. 2024;25(21):11353. doi:10.3390/ijms252111353

BibTeX
@article{Kaltschmidt2024,
  author = {Kaltschmidt, Barbara and Czaniera, Nele Johanne and Schulten, Wiebke and Kaltschmidt, Christian},
  title = {NF-κB in Alzheimer’s Disease: Friend or Foe? Opposite Functions in Neurons and Glial Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {21},
  pages = {11353},
  doi = {10.3390/ijms252111353}
}
Kostenlos starten →